55
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Using ‘omic’ technology to target Helicobacter pylori

, BSc PhD
Pages 1041-1051 | Published online: 17 Aug 2007

Bibliography

  • PRINZ C, SCHWENDY S, VOLAND P: H. pylori and gastric cancer: shifting the global burden. World J. Gastroenterol. (2006) 12:5458-5464.
  • EKSTROM AM, HELD M, HANSSON LE, ENGSTRAND L, NYREN O: Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroeneterology (2001) 121:784-791.
  • KUSTERS JG, VAN VLIET AHM, KUIPERS EJ: Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. (2006) 19:449-490.
  • WERMEILLE J, CUNNINGHAM M, DEDERDING JP et al.: Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol. Clin. Biol. (2002) 26:216-219.
  • GERRITS MM, VAN VLIET AHM, KUIPERS EJ, KUSTERS JG: Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect. Dis. (2006) 6:699-709.
  • LAI C-H, KUO C-H, CHEN P-Y, POON S-K, CHANG C-S, WANG W-C: Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates. J. Antimicrob. Chemother. (2006) 57:466-471.
  • TOMB JF, WHITE O, KERLAVAGE AR et al.: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 388:539-547.
  • ALM RA, LING LS, MOIR DT et al.: Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature (1999) 397:179-180.
  • SALAMA N, GUILLEMIN K, MCDANIEL TK, SHERLOCK G, TOMPKINS L, FALKOW S: A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc. Natl. Acad. Sci. USA (2000) 97:14668-14673.
  • DIEHN M, RELMAN DA: Comparing functional genomic datasets: lessons from DNA microarray analyses of host-pathogen interactions. Curr. Opin. Microbiol. (2001) 4:95-101.
  • BURY-MONE S, THIBERGR J-M, CONTRERAS M, MAITOURNAM A, LABIGNE A, DE REUSE H: Responsiveness to acidity via metal ion regulators mediates virulence in the gastric pathogen Helicobacter pylori. Mol. Microbiol. (2004) 53:623-638.
  • ERNST FD, BERESWILL S, WAIDNER B et al.: Transcriptional profiling of Helicobacter pylori Fur- and iron-regulated gene expression. Microbiology (2005) 151:533-546.
  • CHIOU C-C, CHAN C-C, SHEU D-L, CHEN K-T, LI Y-S, CHAN E-C: Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut (2001) 48:598-604.
  • WEN S, FELLEY CP, BOUZOURENE H, REIMERS M, MICHETTI P, PAN-HAMMARSTROM Q: Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans. J. Immunol. (2004) 172:2595-2606.
  • CHEN G, GHARIB TG, HUANG C-C et al.: Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer. Res. (2002) 8:2298-2305.
  • BROTZ-OESTERHELT H, BANDOW JE, LABISCHINSKI H: Bacterial proteomics and its role in antibacterial drug discovery. Mass Spectr. Rev. (2005) 24:549-565.
  • GEVAERT K, VANDEKERCKHOVE J: Protein identification methods in proteomics. Electrophoresis (2000) 21:1145-1154.
  • HANASH S: Disease proteomics. Nature (2003) 422:226-232.
  • HYNES SO, MCGUIRE J, WADSTROM T: Potential for proteomic profiling of Helicobacter pylori and other Helicobacter spp. Using a Proteinchip® array. FEMS Imm. Med. Microbiol. (2003) 36:151-158.
  • HAN F-C, LI X-J, JIANG H et al.: Detection of H. pylori antibody profile in serum by protein array. World J. Gastroenterol. (2006) 12:4044-4048.
  • MILLS SD: When will the genomics investment pay off for antibacterial discovery? Biochem. Pharmacol. (2006) 71:1096-1102.
  • BINNEWIES TT, MOTRO Y, HALLIN PF et al.: Ten years of bacterial genome sequencing: comparative-genomics-based discoveries. Funct. Integr. Genomics (2006) 6:165-185.
  • ZHANG R, ZHANG C-T: The impact of comparative genomics on infectious disease research. Microbes Infect. (2006) 8:1613-1622.
  • CHALKER AF, MINEHART HW, HUGHES NJ: Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis. J. Bacteriol. (2001) 183:1259-1268.
  • DUTTA A, SINGH SK, GHOSH P, MUKHERJEE R, MITTER S, BANDYOPADHYAY D: In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In Silico Biol. (2006) 6:43-47.
  • SCHILLING CH, COVERT MW, FAMILI I, CHURCH GM, EDWARDS JS, PALSSON BO: Genome-scale metabolic model of Helicobacter pylori 26695. J. Bacteriol. (2002) 184:4582-4593.
  • THIELE I, VO TD, PRICE ND, PALSSON BO: Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterisation of single and double-deletion mutants. J. Bacteriol. (2005) 187:5818-5830.
  • BIJLSMA JJE, VANDENBROUCKE-GRAULS CMJE, PHADNIS SH, KUSTERS JG: Identification of virulence genes of Helicobacter pylori by random insertion mutagenesis. Infect. Immun. (1999) 67:2433-2440.
  • BIJLSMA JJ, LIE-A-LING M, NOOTENBOOM IC, VANDENBROUCKE-GRAULS CM, KUSTERS JG: Identification of loci essential for the growth of Helicobacter pylori under acidic conditions. J. Infect. Dis. (2000) 182:1566-1569.
  • KAVERMANN H, BURNS BP, ANGERMULLER K et al.: Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J. Exp. Med. (2003) 197:813-822.
  • SALAMA NR, SHEPHERD B, FALKOW S: Global transposon mutagenesis and essential gene analysis of Helicobacter pylori. J. Bacteriol. (2004) 186:7926-7935.
  • BALDWIN DN, SHEPHERD B, KRAEMER P et al.: Identification of Helicobacter pylori genes that contribute to stomach colonization. Infect. Immun. (2007) 75:1005-1016.
  • GARBOM S, FORSBERG A, WOLF-WATZE H, KIHLBERG B-M: Identification of novel virulence associated genes via genome analysis of hypothetical genes. Infect. Immun. (2004) 72:1333-1340.
  • CHUANG M-H, WU M-S, LIN J-T, CHIOU S-H: Proteomic analysis of proteins expressed by Helicobacter pylori under oxidative stress. Proteomics (2005) 5:3895-3901.
  • HUTTER B, SCHAAB C, ALBRECHT S et al.: Prediction of mechanism of action of antibacterial compounds by gene expression profiling. Antimicrob. Agents Chemother. (2004) 48:2838-2844.
  • FREIBERG C, BRUNNER N, MACKO L, FISCHER HP: Discovering antibiotic efficacy markers. Mol. Cell. Proteomics (2006) 5:2326-2335.
  • HUTTER B, FISCHER C, JACOBI A, SCHAAB C, LOFERER H: Panel of Bacillus subtilis reporter strains indicative of various modes of action. Antimicrob. Agents Chemother. (2004) 48:2588-2594.
  • FREIBERG C, BROTZ-OESTERHELY H, LABISCINSKI H: The impact of transcriptome and proteome analyses on antibiotic drug discovery. Curr. Opin. Microbiol. (2004) 7:451-459.
  • FISCHER HP, BRUNNER NA, WIELAND B et al.: Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery. Genome Res. (2004) 14:90-98.
  • FREIBERG C, FISCHER HP, BRUNNER NA: Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants. Antimicrob. Agents Chemother. (2005) 49:749-759.
  • FREIBERG CF, POHLMANN J, NELL PG et al.: Novel bacterial acetyl coenzyme A carboxylase inhibitors with antibiotic efficacy in vivo. Antimicrob. Agents Chemother. (2006) 50:2707-2712.
  • BANDOW JE, BROTZ H, LEICHERT LIO, LABISCHINSKI H, HECKER M: Proteomic approach to understanding antibiotic action. Antimicrob. Agents Chemother. (2003) 47:947-955.
  • BANDOW JE, HECKER M: Proteomic profiling of cellular stresses in Bacillus subtilis reveals cellular networks and assists in elucidating antibiotic mechanisms of action. Prog. Drug Res. (2007) 64:81-101.
  • APFEL CM, LOCHER H, EVERS S et al.: Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob. Agents Chemother. (2001) 45:1058-1064.
  • EVERS S, DIPADOVA K, MEYER M et al.: Mechanism-related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional and translational inhibitors. Proteomics (2001) 1:522-544.
  • AEBISCHER T, SCHMITT A, WALDUCK AK, MEYER TF: Helicobacter pylori vaccine development: facing the challenge. Int. J. Med. Microbiol. (2005) 295:343-353.
  • BUMANN D, JUNGBLUT PR, MEYER TF: Helicobacter pylori vaccine development based on combined subproteome analysis. Proteomics (2004) 4:2843-2848.
  • JUNGBLUT PR, BUMANN D, HAAS G et al.: Comparative proteome analysis of Helicobacter pylori. Mol. Microbiol. (2000) 36:710-725.
  • BUMANN D, HOLLAND P, SIEJAK F: A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening. Infect. Immun. (2002) 70:6494-6498.
  • MCATEE CP, LIM MY, FUNG K et al.: Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by two-dimensional gel electrophoresis, sequence analysis and serum profiling. Clin. Diag. Lab. Immunol. (1998) 5:537-542.
  • MCATEE CP, LIM MY, FUNG K et al.: Characterization of a Helicobacter pylori vaccine candidate by proteome techniques. J. Chroma. B. Biomed. Sci. Appl. (1998) 714:325-333.
  • SABARTH N, HURVITZ R, SCHMIDT M et al.: Identification of Helicobacter pylori surface proteins by selective proteinase K digestion and antibody phage display. J. Microbiol. Methods (2005) 62:345-349.
  • LOCK RA, COOMBS GW, MCWILLIAMS TM et al.: Proteome analysis of highly immunoreactive proteins of Helicobacter pylori. Helicobacter (2002) 7:175-182.
  • CHAKRAVARTI DN, FISKE MJ, FLETCHER LD, ZAGURSKY RJ: Application of genomics and proteomics for identification of bacterial gene products as potential vaccine candidates. Vaccine (2001) 19:601-612.
  • KIMMEL B, BOSSERHOFF A, FRANK R, GROSS R, GOEBEL W, BEIER D: Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect. Immun. (2000) 68:915-920.
  • HAAS G, KARAALI G, EBERMAYER K et al.: Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics (2002) 2:313-324.
  • SABARTH N, LAMER S, ZIMNY-ARNDT U, JUNGBLUT PR, MEYER TF: Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis. J. Biol. Chem. (2002) 277:27896-27902.
  • UTT M, NILSSON I, LJUNGH A, WADSTROM T: Identification of novel immunogenic proteins of Helicobacter pylori by proteome technology. J. Immunol. Methods (2002) 259:1-10.
  • BAIK S-C, KIM K-M, SONG S-M et al.: Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Helicobacter pylori strain 26695. J. Bacteriol. (2004) 186:949-955.
  • SUAREZ G, REYES VE, BESWICK EJ: Immune response to H. pylori. World J. Gastrenterol. (2006) 12:5593-5598.
  • SABARTH N, HURWITZ R, MEYER TF, BUMANN D: Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy. Infect. Immun. (2002) 70:6499-6503.
  • WALDUCK A, SCHMITT A, LUCAS B, AESBISCHER T, MEYER TF: Transcriptional profiling analysis of the mechanisms of vaccine-induced protection against H. pylori. FASEB J. (2004) 18:1955-1957.
  • MUELLER A, O'ROURKE J, CHU P et al.: Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc. Natl. Acad. Sci. USA (2003) 100:12289-12294.
  • THOMPSON LJ, MERRELL DS, NEILAN BA, MITCHELL H, LEE A, FALKOW S: Gene expression profiling of Helicobacter pylori reveals a growth – phase-dependant switch in virulence gene expression. Infect. Immun. (2003) 71:2643-2655.
  • KIM N, MARCUS EA, WEN Y et al.: Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect. Immun. (2004) 72:2358-2368.
  • GRAHAM JE, PEEK RM, KRISHNA U, COVER TL: Global analysis of Helicobacter pylori gene expression in human gastric mucosa. Gastroenterology (2002) 123:1637-1648.
  • WU M-S, CHEN C-J, LIN J-T: Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol. Biomarkers Prev. (2005) 14:1878-1882.
  • RAD R, DOSSUMBEKOVA A, NEU B et al.: Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut (2004) 53:10821089.
  • EL-OMAR EM: Role of host genes in sporadic gastric cancer. Best Pract. Res. Clin. Gastroenterol. (2006) 20:675-686.
  • BACKERT S, GRESSMANN H, KWOK T et al.: Gene expression and protein profiling of AGS gastric epithelial cells upon infection with Helicobacter pylori. Proteomics (2005) 5:3902-3918.
  • HUFF JL, HANSEN LM, SOLNICK JV: Gastric transcription profile of Helicobacter pylori infection in the rhesus macaque. Infect. Immun. (2004) 72:5216-5226.
  • RESNICK MB, SABO E, MEITNER PA et al.: Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. Gut (2006) 55:1717-1724.
  • JUHASZ M, HERSZENYI L, TULASSAY Z, MALFERTHEINER P, EBERT MPA: Helicobacter pylori and molecular mechanism of gastric carcinogenesis: targets for prevention and therapy. Expert Rev. Anticancer Ther. (2004) 4:97-103.
  • LIN Y-F, CHEN CY, TSAI MH et al.: Duodenal ulcer-related antigens from Helicobacter pylori: immunoproteomes and protein microarray approaches. Mol. Cell. Proteomics (2007) [Epub ahead of print].
  • LIN YF, WU M-S, CHANG C-C et al.: Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol. Cell. Proteomics (2006) 5:1484-1496.
  • ISRAEL DA, SALAMA N, ARNOLD CN: Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Invest. (2001) 107:611-620.
  • PALLI D, MASALA G, DEL GIUDICE G et al.: CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int. J. Cancer (2007) 120:859-867.
  • AHMED N, SECHI LA: Helicobacter pylori and gastroduodenal pathology: new threats of the old friend. Ann. Clin. Microbiol. Antimicrob. (2005) 4:1.
  • WANG HT, LI ZH, YUAN JP: Effect of Helicobacter pylori VacA on gene expression of gastric cancer cells. World J. Gastroenterol. (2005) 11:109-113.
  • AKHTER Y, AHMED I, DEVI SM, AHMED N: The co-evolved Helicobacter pylori and gastric cancer: trinity of bacterial virulence, host susceptibility and lifestyle. Infect. Agents Cancer (2007) 2:2.
  • ISRAEL DA, SALAMA N, KRISHNA U et al.: Helicobacter pylori genetic diversity within the gastric niche of a single host. Proc. Natl. Acad. Sci. USA (2001) 98:14625-14630.
  • KRAFT C, STACK A, JOSENHANS C et al.: Genomic changes during chronic Helicobacter pylori infection. J. Bacteriol. (2006) 188:249-254.
  • KRAFT C, SUERBAUM S: Mutation and recombination in Helicobacter pylori: mechanism and role in generating strain diversity. Int. J. Med. Microbiol. (2005) 295:299-305.
  • CARROLL IM, KHAN AA, AHMED N: Revisiting the pestilence of Helicobacter pylori: insights into geographical genomics and pathogen evolution. Infect. Gene Evol. (2004) 4:81-90.
  • FALUSH D, WIRTH T, LINZ B et al.: Traces of human migrations in Helicobacter pylori populations. Science (2003) 299:1582-1585.
  • GRESSMANN H, LINZ B, GHAI R et al.: Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet. (2005) 1:e43.
  • OH JD, KLING-BACKHEAD H, GIANNAKIS M et al.: The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc. Natl. Acad. Sci. USA (2006) 103:9999-10004.
  • PENNISI E: Biochemistry. Cut-rate genomes on the horizon? Science (2005) 309:862.
  • GUSTAFSON AM, SNITKIN ES, PARKER SCJ, DELISI C, KASIF S: Towards the identification of essential genes using targeted genome sequencing and comparative analysis. BMC Genomics (2006) 7:265.
  • JOYCE AR, REED JL, WHITE A et al.: Experimental and computational assessment of conditionally essential genes in Escherichia coli. J. Bacteriol. (2006) 188:8259-8271.
  • VAN AMSTERDAM K, VAN VLIET AHM, KUSTERS JG, VAN DER ENDE A: Of microbe and man: determinants of Helicobacter pylori-related diseases. FEMS Microbiol. Rev. (2006) 30:131-156.
  • GAO Y, HU G, LIN FYH, SHERMAN PM, LI D: An electrokinetically-controlled immunoassay for simultaneous detection of multiple microbial antigens. Biomed. Microdevices (2005) 7:301-312.
  • ELLMARK P, INGVARSSON J, CARLSSON A, LUNDIN BS, WINGREN C, BORREBAECK CAK: Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol. Cell. Proteomics (2006) 5:1638-1649.
  • PAYNE DJ, GWYNN MN, HOLMES DJ, POMPLINO DL: Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. (2007) 6:29-40.
  • UWINS C, DEITRICH C, ARGO E, STEWART E, DAVIDSON I, CASH P: Growth-induced changes in the proteome of Helicobacter pylori. Electrophoresis (2006) 27:1136-1146.
  • PLEISNER K-P, EIFERT T, BUETTNER S et al.: Web-accessible proteome databases for microbial research. Proteomics (2004) 4:1305-1313.
  • AHMED N, MAJEED AA, AHMED I et al.: GenoBASE pylori: a genotype search tool and database of the human gastric pathogen Helicobacter pylori. Infect. Genet. Evol. (2007) [Epub ahead of print].
  • FIELD D, WILSON G, VAN DER GAST C: How do we compare hundreds of bacterial genomes? Curr. Opin. Microbiol. (2006) 9:499-504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.